The two widows of the only Americans known to have died as a
result of donating a portion of their liver for transplantation
are urging that new procedures be put in place to better inform
potential donors of the risk.
At present, potential liver donors have no way to accurately
assess the risk of death or serious complications that they face
in having this highly challenging surgery because a national registry
that would track all living liver donor outcomes does not exist.
"My husband was at the mercy of what his surgeons chose
to tell him," said Rhonda Boone, wife of 41-year-old Danny
Boone, who died three weeks after donating part of his liver to
his brother in 1999 at the University of North Carolina Liver
Transplant Program at Chapel Hill.
Vickie Hurewitz, whose 57-year-old husband Mike died three days
after donating part of his liver to his brother in January at
Mount Sinai Hospital in New York, said "once Mike found he
was a match for his brother, he didn't ask any questions at all.
He told me he felt he didn't have any choice."
A number of bioethicists suggest that the strong motivation of
donors like Boone and Hurewitz, coupled with a lack of accurate
information about complications such as embolisms, bile leaks
and damage to nearby organs, often makes a mockery of the idea
of "informed consent."
Surgeons privately also suggest that in the absence of any reporting
requirement, additional deaths many have gone unreported in the
last few years among the more than 700 liver donors in the United
States -- in addition to the three deaths reported to have occurred
in Europe.
They also note that there currently is no process for tracking
donor morbidity -- complications suffered by the donor somewhere
between 10 and 40 percent of the time -- as a way of better informing
prospective donors of the risks. One donor at Georgetown University
Medical Center, for example, reportedly experienced liver failure,
and wound up needing a liver transplant himself.
Hurewitz and Boone also echoed a complaint heard from many living
donors -- of kidneys as well as livers -- that members of the
transplant team seemed far more interested post-surgery in the
recipient than in the donor.
"My impression of these people is . . . (all) they care
about was they got 60 percent of his liver out of him," said
Hurewitz. Boone and Hurewitz are planning to meet next month to
talk about ways of better protecting other potential healthy liver
donors.
"There needs to be a national debate on it ... we're still
debating abortion, we're debating stem cell research. How the
hell are we just letting this procedure go? '' asked Hurewitz.
"It's not regulated by anybody, anywhere. There's no national
standards.''